Applied DNA regains compliance with Nasdaq continued listing requirements
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 07 2025
0mins
Compliance with Nasdaq Requirements: Applied DNA Sciences has regained compliance with Nasdaq Listing Rule 5550(a)(2), confirming that its share price is above the minimum requirement of $1.00 per share.
Cancellation of Hearing: The scheduled hearing before the Nasdaq Hearings Panel on July 15, 2025, has been cancelled, allowing the company's securities to continue being listed and traded on the Nasdaq Capital Market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
